Monitoring ADMA Levels the Key to Avoiding Cardiovascular Disease?

Monitoring ADMA Levels the Key to Avoiding Cardiovascular Disease?

Rheumatology February 2, 2015 at 9:10 AM 0 comments

FEARFUL side-effects that have prohibited the appearance of certain anti-inflammatory arthritis drugs in our pharmacies could soon become irrelevant, after researchers uncover a potential test to identify just who should avoid COX-2 inhibitors. COX-2 inhibitors, a type of non-steroidal anti-inflammatory drug (NSAID), are widely used for providing pain relief toRead More

Quick Imaging Unlocks Path to Valvular Heart Disease Treatment

Quick Imaging Unlocks Path to Valvular Heart Disease Treatment

Cardiology January 26, 2015 at 9:30 AM 0 comments

ACCURACY of the physical diagnoses of heart conditions is boosted through the use of a handheld ultrasound device, with more successful diagnoses of valvular heart disease (VHD) compared to traditional methods. Traditionally identified through the detection of a heart murmur using a stethoscope, VHD may be detected by an echocardiogramRead More

Key to Heart Attack Treatment May Come from Within

Key to Heart Attack Treatment May Come from Within

Cardiology January 26, 2015 at 9:25 AM 0 comments

INTRACORONARY injection of a patient’s own bone marrow (BM) cells could emerge as the ultimate treatment for heart attacks. Selected for their healing potential, a particular group of BM cells – known as endothelial progenitor cells – are believed to trigger healing and blood flow recovery. In the PreSERVE-AMI PhaseRead More

Basilea Announces That FDA’s Anti-Infective Drugs Advisory Committee Recommends Approval of Isavuconazole for the Treatment of Invasive Aspergillosis and Mucormycosis

Uncategorized January 23, 2015 at 2:25 PM 0 comments

Basel, Switzerland, January 22, 2015 – Basilea Pharmaceutica Ltd. (SIX: BSLN) today announced that the U.S. Food and Drug Administration’s (FDA) Anti-Infective Drugs Advisory Committee voted unanimously to recommend approval of the investigational once-daily intravenous and oral antifungal isavuconazole, the active moiety of the prodrug isavuconazonium sulfate, for the treatmentRead More

Medac GmbH Supports Guideline on Intravesical Instillations of BCG/MMC

Uncategorized January 20, 2015 at 3:10 PM 0 comments

Hamburg / Wedel (20 January 2015). medac GmbH has provided the European Association of Urology Nurses (EAUN) with an unrestricted educational grant to support the creation of a booklet “Guideline on intravesical instillations of BCG/MMC”.  Over the past 30 years medac has provided urologists with their expertise and products forRead More

THSD7A: Another Hope for Membranous Nephropathy Sufferers

THSD7A: Another Hope for Membranous Nephropathy Sufferers

Nephrology January 19, 2015 at 10:08 AM 0 comments

IDENTIFICATION of a protein, thrombospondin type-1 domain-containing protein 7A (THSD7A), that turns a person’s immune system against itself in sufferers of membranous nephropathy (MN) could give patients a fighting chance now that a blood test can be developed to diagnose and monitor this prevalent type of kidney disease. MN isRead More

Stem Cells: The Cellular Origins of Fibrosis

Stem Cells: The Cellular Origins of Fibrosis

Nephrology January 19, 2015 at 9:56 AM 0 comments

POTENTIAL culprits that give rise to chronic tissue scarring, which can lead to the development of fibrosis, have been identified as a rare population of stem cells (SCs). Tissue scarring caused by organ damage is associated with a multitude of health conditions such as: diabetes, lung disease, high blood pressureRead More

Artificial Liver Leads the Way as New Life-Saver

Artificial Liver Leads the Way as New Life-Saver

Gastroenterology January 12, 2015 at 10:07 AM 0 comments

BIOARTIFICIAL livers could possess the ability to sustain liver failure (LF) patients until their own internal organs can repair themselves or a matching donor is found. For many end-stage liver disease (ESLD) and acute LF patients, transplantation is their final hope. Yet amazingly, only 3,000 organs are available for aRead More

Could New Cure Conquer Crohn’s in 2015?

Could New Cure Conquer Crohn’s in 2015?

Gastroenterology January 12, 2015 at 10:03 AM 0 comments

SUFFERERS of Crohn’s disease (CrD) worldwide could potentially be one step away from reaping the benefits of a cure for their condition, changing lives on a global scale. Prof John Hermon-Taylor, Visiting Professor, King’s College London, London, UK, who has spent the last 30 years dedicating his life to findingRead More

Liver Cancer Menace May Lie in Surrounding Immunity

Liver Cancer Menace May Lie in Surrounding Immunity

Hepatology January 6, 2015 at 9:34 AM 0 comments

MACROPHAGES may constitute the next target for liver cancer treatment as the presence of epidermal growth factor receptor (EGFR) in the cells surrounding tumour cells have been shown to catalyse tumour proliferation. Several years ago EGFR was found to occupy and promote the development of up to 70% of totalRead More